Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

SCFSkp2-IN-2

🥰Excellent
Catalog No. T72043Cas No. 1375060-02-8

SCFSkp2-IN-2, a Skp2 inhibitor, exhibits a dissociation constant (K_D) of 28.77 μM. It demonstrates antitumor activities by inducing apoptosis in non-small cell lung cancer (NSCLC) cells.

SCFSkp2-IN-2

SCFSkp2-IN-2

🥰Excellent
Purity: 99.28%
Catalog No. T72043Cas No. 1375060-02-8
SCFSkp2-IN-2, a Skp2 inhibitor, exhibits a dissociation constant (K_D) of 28.77 μM. It demonstrates antitumor activities by inducing apoptosis in non-small cell lung cancer (NSCLC) cells.
Pack SizePriceAvailabilityQuantity
10 mg$38In Stock
25 mg$77In Stock
50 mg$128In Stock
100 mg$223In Stock
200 mg$328In Stock
1 mL x 10 mM (in DMSO)$30In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "SCFSkp2-IN-2"

Select Batch
Purity:99.28%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
SCFSkp2-IN-2, a Skp2 inhibitor, exhibits a dissociation constant (K_D) of 28.77 μM. It demonstrates antitumor activities by inducing apoptosis in non-small cell lung cancer (NSCLC) cells.
Targets&IC50
Skp2:28.77 μM(kd)
In vitro
SCFSkp2-IN-2 (Compound AAA-237) (0.3-3 μM; 24-72 h) binds directly to Skp2, leading to its proteasome-mediated degradation without affecting Skp2 mRNA expression but inhibiting Skp2 protein expression in a time-dependent manner in NSCLC cells. SCFSkp2-IN-2 inhibits the proliferation of A549 and H1299 cells and induces apoptosis in a dose- and time-dependent manner, blocks the cell cycle at the G0/G1 checkpoint by regulating the Skp2-Cip/Kip and PI3K/Akt-FOXO1 signaling pathways, and induces NSCLC cell senescence (0.3 μM; 1-7 days).[1]
In vivo
SCFSkp2-IN-2 (Compound AAA-237) administered at 15 or 45 mg/kg intraperitoneally on a daily basis for 14 days demonstrated antitumor activity in an A549 lung cancer xenograft mouse model.[1]
Chemical Properties
Molecular Weight312.37
FormulaC17H20N4O2
Cas No.1375060-02-8
SmilesN(CC)(CC)C1=CC(O)=C(/C=N/NC(=O)C=2C=CC=NC2)C=C1
Storage & Solubility Information
StorageShipping with blue ice.
Solubility Information
DMSO: 112.5 mg/mL (360.2 mM ), Sonication and heating to 60℃ are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2013 mL16.0067 mL32.0133 mL160.0666 mL
5 mM0.6403 mL3.2013 mL6.4027 mL32.0133 mL
10 mM0.3201 mL1.6007 mL3.2013 mL16.0067 mL
20 mM0.1601 mL0.8003 mL1.6007 mL8.0033 mL
50 mM0.0640 mL0.3201 mL0.6403 mL3.2013 mL
100 mM0.0320 mL0.1601 mL0.3201 mL1.6007 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SCFSkp2-IN-2 | purchase SCFSkp2-IN-2 | SCFSkp2-IN-2 cost | order SCFSkp2-IN-2 | SCFSkp2-IN-2 chemical structure | SCFSkp2-IN-2 in vivo | SCFSkp2-IN-2 in vitro | SCFSkp2-IN-2 formula | SCFSkp2-IN-2 molecular weight